Impact of Prolapse Width on Outcomes of Transcatheter Edge-to-Edge Repair in Degenerative Mitral Regurgitation

Manchen Gao1, Jianrui Ma1, Yuxiang Tang2

  • 1Department of Structural Heart Disease, National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine, State Key Laboratory of Cardiovascular Disease, Key Laboratory of Innovative Cardiovascular Devices, Chinese Academy of Medical Sciences, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Insights

Transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation (DMR) is optimized when prolapse width is less than 14mm. A width greater than 14mm predicts higher adverse events, regardless of clip number.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Transcatheter edge-to-edge repair (TEER) is a key treatment for high-risk degenerative mitral regurgitation (DMR).
  • The extent of leaflet lesions manageable with a single clip during TEER is not fully understood.
  • This study investigates the range of leaflet lesions treatable with one clip in DMR patients.

Purpose of the Study:

  • To determine the anatomical factors influencing successful first-clip outcomes in TEER for DMR.
  • To establish a predictive threshold for prolapse width in TEER procedures.
  • To correlate prolapse width with adverse event rates post-TEER.

Main Methods:

  • Retrospective analysis of intraoperative echocardiograms from 106 DMR patients undergoing TEER.
  • Logistic regression to identify anatomical predictors of satisfactory first-clip results.
  • Receiver-operator characteristic (ROC) curve analysis to determine optimal cut-off values for predictors.

Main Results:

  • Prolapse width and prolapse gap were independent predictors of satisfactory first-clip results.
  • Optimal prolapse width cut-off was 14mm (sensitivity 74.6%, specificity 95.3%).
  • Patients with prolapse width >14mm experienced significantly higher adverse event rates (p=0.007).

Conclusions:

  • Prolapse width is a critical predictor of TEER outcomes after the first clip.
  • A prolapse width exceeding 14mm is associated with increased postoperative severe adverse events.
  • This finding holds true irrespective of the total number of clips used in the procedure.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
352
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
257
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
385
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
266
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
287